Psychedelic APIs

Pharmaceutical-Grade. Ready to Support Clinical Trials.

Purisys has industry-leading expertise and capabilities to manufacture Schedule I psychedelic compounds for human pharmaceutical applications.

  • Psilocybin
  • Psilocin
  • MDMA and related derivatives
  • LSD
  • DMT and related derivatives
  • Ketamine
  • Ibogaine

Our API CDMO offering effectively integrates end-to-end project management, process development services, analytical services, regulatory support, and cGMP manufacturing of custom psychedelic compounds to rapidly advance your API to the clinic.

Psychedelic-specific services

In a young and rapidly developing marketplace, psychedelic drug innovators can benefit from our experience and proven track record of success.

Manufactured in FDA-inspected and DEA-licensed facilities, our psychedelic APIs and reference standards support companies in early to late-phase clinical development. While other CDMOs may only be able to provide non-GMP grades of material, Purisys can support our customers from pre-clinical to commercial and all stages in between.

We can also help you navigate the regulatory and logistical hurdles associated with global shipments and permits for psychedelic APIs.

At a Glance

  • Proven API CDMO services
  • Extensive development of numerous psychedelic APIs
  • Broad experience with pharma-grade APIs ready to support clinical trials
  • Skilled handling of high potency/controlled substances
  • Industry-leading experience with global logistics
  • Preclinical to IND/INMD to NDA/ANDA/MAA phase regulatory expertise
Connect With Us